Hjem › Mavekreft › Texas › Dallas
Kliniske studier for Mavekreft i Dallas, TX
19 studier for Mavekreft søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- UT Southwestern, Dallas
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
RekruttererFase 3
- Baylor Scott & White Health, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
- Baylor, Scott and White Research Institute, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, Dallas
- Research Site, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Mary Crowley Cancer Research, Dallas
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
RekruttererFase 3
- UT Southwestern Medical Center, Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Texas Oncology, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- og 2 flere
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RekruttererFase 2
- Texas Oncology - DFW, Dallas
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
RekruttererFase 2
- Texas Oncology Dallas Methodist, Dallas
- Texas Oncology Dallas Medical City, Dallas
- Texas Oncology Dallas Presbyterian, Dallas
- og 2 flere
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RekruttererFase 1/2
- University of Texas Southwestern Medical Center, Dallas
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Baylor University Medical Center, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekruttererFase 1
- NEXT Dallas, Dallas
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Dallas
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
- University of Texas Southwestern Medical Center, Dallas
Mavekreft-studier i andre byer
- Houston, TX42 studier
- Boston, MA32 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Baldwin Park, CA22 studier
- Los Angeles, CA22 studier
- Arlington, VA20 studier
- San Antonio, TX19 studier
- St. Louis, MO18 studier
- Grand Rapids, MI18 studier
- Washington, DC16 studier
- Chicago, IL16 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Lungekreft27 studier
- Blærekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.